Biotech diversity is still lacking, BIO finds

In a report released Thursday, BIO detailed the results of its inaugural diversity survey that found biotech boards and C-suites are still overwhelmingly white and male, which in turn can make it harder for companies to hire a diverse team.

The report, “Measuring Diversity in the Biotech Industry: Building an Inclusive Workforce,” is the latest in a series of BIO initiatives focused on diversity. The trade group adopted five guiding diversity principles in 2017 and last year launched its Right Mix Matters campaign to provide tools to increase gender, racial, ethnic and LGBTQ representation on biotech boards and in leadership positions (see "Rise of the First-Time Biotech CEO")...